pfizer glp 1 news ADA '26: Lilly's dominance, Pfizer's 'foundational' drug and Roche's 'me-too' option Pfizer Is Going All In

The trial demonstrated that once-weekly tirzepatide 10 mg and 15 mg offered substantial and clinically meaningful bodyweight reduction, with a safety profile similar to other therapies for weight management using incretin-based approaches

Contrave Dosage for Weight Loss: The 4-Week Titration Schedule Understanding contrave dosage for weight loss matters because getting the titration right is exactly what separates people who tolerate it well from those who quit after week one

CBSs spending on immunoglobulin has doubled in the last 10 years, and CBS expects demand to increase another 50 per cent over the next five years

Novel distribution revealed with extensively validated monoclonal antibody